Post-translational modification and regulation of actin

Current Opinion in Cell Biology

Volumn 25, Issue 1, 2013, Pages 30-38

  Terman, Jonathan R ^a   Kashina, Anna ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; F ACTIN; HISTIDINE; PROTEIN KINASE C; TRYPTOPHAN; TYROSINE;

ACETYLATION; ADENOSINE DIPHOSPHATE RIBOSYLATION; AMINO TERMINAL SEQUENCE; CARBONYLATION; ENVIRONMENTAL STRESS; GLYCOSYLATION; METABOLIC STRESS; METHYLATION; NITRATION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; UBIQUITINATION;

EID: 84873731427     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.10.009     Document Type: Review

References (99)

1. Pollard T.D., Cooper J.A. Actin, a central player in cell shape and movement. Science 2009, 326:1208-1212.
2. Vandekerckhove J., Weber K. Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins. Proc Natl Acad Sci U S A 1978, 75:1106-1110.
3. Cook R.K., Sheff D.R., Rubenstein P.A. Unusual metabolism of the yeast actin amino terminus. J Biol Chem 1991, 266:16825-16833.
4. Mottet D., Castronovo V. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 2008, 25:183-189.
5. Anderson K.A., Hirschey M.D. Mitochondrial protein acetylation regulates metabolism. Essays Biochem 2012, 52:23-35.
6. Starheim K.K., Gevaert K., Arnesen T. Protein N-terminal acetyltransferases: when the start matters. Trends Biochem Sci 2012, 37:152-161.
7. Kovacs J.J., Hubbert C., Yao T.P. The HDAC complex and cytoskeleton. Novartis Found Symp 2004, 259:170-177. discussion 178-181, 223-175.
8. Maas A. Viewpoint: Angela Maas, MD, PhD. Interview by Jennifer Taylor. Circulation 2007, 116:f91-f93.
9. Yildirim F., Gertz K., Kronenberg G., Harms C., Fink K.B., Meisel A., Endres M. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol 2008, 210:531-542.
10. Obrdlik A., Kukalev A., Louvet E., Farrants A.K., Caputo L., Percipalle P. The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription. Mol Cell Biol 2008, 28:6342-6357.
11. Sheterline P., Clayton J., Sparrow J. Actin. Protein Profile 1995, 2:1-103.
12. Aktories K., Lang A.E., Schwan C., Mannherz H.G. Actin as target for modification by bacterial protein toxins. FEBS J 2011, 278:4526-4543.
13. Okamoto H., Fujita H., Matsuyama S., Tsuyama S. Purification, characterization, and localization of an ADP-ribosylactin hydrolase that uses ADP-ribosylated actin from rat brains as a substrate. J Biol Chem 1997, 272:28116-28125.
14. Karakozova M., Kozak M., Wong C.C.L., Bailey A.O., Yates J.R., Mogilner A., Zebroski H., Kashina A. Arginylation of beta-actin regulates actin cytoskeleton and cell motility. Science 2006, 313:192-196.
15. Kashina A.S. Differential arginylation of actin isoforms: the mystery of the actin N-terminus. Trends Cell Biol 2006, 16:610-615.
16. Wong C.C., Xu T., Rai R., Bailey A.O., Yates J.R., Wolf Y.I., Zebroski H., Kashina A. Global analysis of posttranslational protein arginylation. PLoS Biol 2007, 5:e258.
17. Rai R., Wong C.C., Xu T., Leu N.A., Dong D.W., Guo C., McLaughlin K.J., Yates J.R., Kashina A. Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart development. Development 2008, 135:3881-3889.
18. Kurosaka S., Leu N.A., Zhang F., Bunte R., Saha S., Wang J., Guo C., He W., Kashina A. Arginylation-dependent neural crest cell migration is essential for mouse development. PLoS Genet 2010, 6:e1000878.
19. Kurosaka S., Leu N.A., Pavlov I., Han X., Ribeiro P.A., Xu T., Bunte R., Saha S., Wang J., Cornachione A., et al. Arginylation regulates myofibrils to maintain heart function and prevent dilated cardiomyopathy. J Mol Cell Cardiol 2012, 53:333-341.
20. Kwon Y.T., Kashina A.S., Davydov I.V., Hu R.G., An J.Y., Seo J.W., Du F., Varshavsky A. An essential role of N-terminal arginylation in cardiovascular development. Science 2002, 297:96-99.
21. Kurosaka S., Kashina A. Cell biology of embryonic migration. Birth Defects Res C: Embryo Today 2008, 84:102-122.
22. Saha S., Mundia M.M., Zhang F., Demers R.W., Korobova F., Svitkina T., Perieteanu A.A., Dawson J.F., Kashina A. Arginylation regulates intracellular actin polymer level by modulating actin properties and binding of capping and severing proteins. Mol Biol Cell 2010, 21:1350-1361.
23. Zhang F., Saha S., Shabalina S.A., Kashina A. Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. Science 2010, 329:1534-1537.
24. Russo L., Marsella C., Nardo G., Massignan T., Alessio M., Piermarini E., La Rosa S., Finzi G., Bonetto V., Bertuzzi F., et al. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E. Acta Diabetol 2012, Mar 3 [Epub ahead of print].
25. Del Duca S., Serafini-Fracassini D., Bonner P., Cresti M., Cai G. Effects of post-translational modifications catalysed by pollen transglutaminase on the functional properties of microtubules and actin filaments. Biochem J 2009, 418:651-664.
26. Katoh S., Inoue T., Kohno H., Ohkubo Y. Transglutaminase-modified actin decreases epidermal growth factor binding to its receptor in rat liver membrane. Biomed Res 1994, 15:1-8.
27. Katoh S., Nakagawa N., Yano Y., Satoh K., Kohno H., Ohkubo Y. Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes. Biochem J 1996, 313(Pt 1):305-309.
28. Nemes Z., Adany R., Balazs M., Boross P., Fesus L. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J Biol Chem 1997, 272:20577-20583.
29. Baumgartner W., Weth A. Transglutaminase 1 stabilizes beta-actin in endothelial cells correlating with a stabilization of intercellular junctions. J Vasc Res 2007, 44:234-240.
30. Dolge L., Aufenvenne K., Traupe H., Baumgartner W. Beta-actin is a target for transglutaminase activity at synaptic endings in chicken telencephalic cell cultures. J Mol Neurosci 2012, 46:410-419.
31. Fofana B., Yao X.H., Rampitsch C., Cloutier S., Wilkins J.A., Nyomba B.L. Prenatal alcohol exposure alters phosphorylation and glycosylation of proteins in rat offspring liver. Proteomics 2010, 10:417-434.
32. Hart G.W., Housley M.P., Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007, 446:1017-1022.
33. Ramirez-Correa G.A., Jin W., Wang Z., Zhong X., Gao W.D., Dias W.B., Vecoli C., Hart G.W., Murphy A.M. O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res 2008, 103:1354-1358.
34. 2+ activation properties of rat skeletal muscle. J Biol Chem 2007, 282:10360-10369.
35. Jones S.P., Zachara N.E., Ngoh G.A., Hill B.G., Teshima Y., Bhatnagar A., Hart G.W., Marban E. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 2008, 117:1172-1182.
36. Akimoto Y., Miura Y., Toda T., Wolfert M.A., Wells L., Boons G.J., Hart G.W., Endo T., Kawakami H. Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including alpha-actinin 4. Clin Proteomics 2011, 8:15.
37. McLean W.G., Pekiner C., Cullum N.A., Casson I.F. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol Neurobiol 1992, 6:225-237.
38. Brown M.R., Keith T.J., Knull H.R. Nonenzymatic incorporation of glucose and galactose into brain cytoskeletal proteins in vitro. Neurochem Int 1992, 21:177-183.
39. Pekiner C., Cullum N.A., Hughes J.N., Hargreaves A.J., Mahon J., Casson I.F., McLean W.G. Glycation of brain actin in experimental diabetes. J Neurochem 1993, 61:436-442.
40. Sulochana K.N., Indra C., Rajesh M., Srinivasan V., Ramakrishnan S. Beneficial role of amino acids in mitigating cytoskeletal actin glycation and improving F-actin content: in vitro. Glycoconj J 2001, 18:277-282.
41. Kuleva N.V., Kovalenko Z.S. Change in the functional properties of actin by its glycation in vitro. Biochemistry (Mosc) 1997, 62:1119-1123.
42. Resmi H., Akhunlar H., Temiz Artmann A., Guner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct 2005, 23:163-168.
43. Vijayasarathy C., Rao B.S. Partial purification and characterisation of S-adenosylmethionine:protein-histidine N-methyltransferase from rabbit skeletal muscle. Biochim Biophys Acta 1987, 923:156-165.
44. Raghavan M., Lindberg U., Schutt C. The use of alternative substrates in the characterization of actin-methylating and carnosine-methylating enzymes. Eur J Biochem 1992, 210:311-318.
45. Saha S., Wong C.C., Xu T., Namgoong S., Zebroski H., Yates J.R., Kashina A. Arginylation and methylation double up to regulate nuclear proteins and nuclear architecture in vivo. Chem Biol 2011, 18:1369-1378.
46. Chiou Y.Y., Fu S.L., Lin W.J., Lin C.H. Proteomics analysis of in vitro protein methylation during Src-induced transformation. Electrophoresis 2012, 33:451-461.
47. Feuer G., Molnar F., Pettko E., Straub F.B. Studies on the composition and polymerization of actin. Hung Acta Physiol 1948, 1:150-163.
48. Milzani A., Rossi R., Di Simplicio P., Giustarini D., Colombo R., DalleDonne I. The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci 2000, 9:1774-1782.
49. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Di Simplicio P., Colombo R., Milzani A. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med 2002, 32:927-937.
50. Hung R.J., Pak C.W., Terman J.R. Direct redox regulation of F-actin assembly and disassembly by Mical. Science 2011, 334:1710-1713.
51. Guan J.Q., Almo S.C., Reisler E., Chance M.R. Structural reorganization of proteins revealed by radiolysis and mass spectrometry: G-actin solution structure is divalent cation dependent. Biochemistry 2003, 42:11992-12000.
52. Guan J.Q., Takamoto K., Almo S.C., Reisler E., Chance M.R. Structure and dynamics of the actin filament. Biochemistry 2005, 44:3166-3175.
53. Takamoto K., Kamal J.K., Chance M.R. Biochemical implications of a three-dimensional model of monomeric actin bound to magnesium-chelated ATP. Structure 2007, 15:39-51.
54. Harris L.K., McCormick J., Cartwright J.E., Whitley G.S., Dash P.R. S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp Cell Res 2008, 314:1765-1776.
55. Webb J.L., Harvey M.W., Holden D.W., Evans T.J. Macrophage nitric oxide synthase associates with cortical actin but is not recruited to phagosomes. Infect Immun 2001, 69:6391-6400.
56. Tamura M., Kai T., Tsunawaki S., Lambeth J.D., Kameda K. Direct interaction of actin with p47(phox) of neutrophil NADPH oxidase. Biochem Biophys Res Commun 2000, 276:1186-1190.
57. Tamura M., Kanno M., Endo Y. Deactivation of neutrophil NADPH oxidase by actin-depolymerizing agents in a cell-free system. Biochem J 2000, 349:369-375.
58. Tamura M., Itoh K., Akita H., Takano K., Oku S. Identification of an actin-binding site in p47phox an organizer protein of NADPH oxidase. FEBS Lett 2006, 580:261-267.
59. Shao D., Segal A.W., Dekker L.V. Subcellular localisation of the p40phox component of NADPH oxidase involves direct interactions between the Phox homology domain and F-actin. Int J Biochem Cell Biol 2010, 42:1736-1743.
60. Rasmussen I., Pedersen L.H., Byg L., Suzuki K., Sumimoto H., Vilhardt F. Effects of F/G-actin ratio and actin turn-over rate on NADPH oxidase activity in microglia. BMC Immunol 2010, 11:44.
61. Li J.M., Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002, 277:19952-19960.
62. Gu Y., Xu Y.C., Wu R.F., Souza R.F., Nwariaku F.E., Terada L.S. TNFalpha activates c-Jun amino terminal kinase through p47(phox). Exp Cell Res 2002, 272:62-74.
63. Wu R.F., Gu Y., Xu Y.C., Nwariaku F.E., Terada L.S. Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 2003, 278:36830-36840.
64. Kang L.T., Vanderhoek J.Y. Mono(S)hydroxy fatty acids: novel ligands for cytosolic actin. J Lipid Res 1998, 39:1476-1482.
65. Kang L.T., Phillips T.M., Vanderhoek J.Y. Novel membrane target proteins for lipoxygenase-derived mono(S)hydroxy fatty acids. Biochim Biophys Acta 1999, 1438:388-398.
66. Lepley R.A., Fitzpatrick F.A. 5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins. J Biol Chem 1994, 269:24163-24168.
67. Su Y., Kondrikov D., Block E.R. Beta-actin: a regulator of NOS-3. Sci STKE 2007, 2007:pe52.
68. Morimatsu T., Kawagoshi A., Yoshida K., Tamura M. Actin enhances the activation of human neutrophil NADPH oxidase in a cell-free system. Biochem Biophys Res Commun 1997, 230:206-210.
69. Miller Y.I., Chang M.K., Funk C.D., Feramisco J.R., Witztum J.L. 12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells. J Biol Chem 2001, 276:19431-19439.
70. Provost P., Doucet J., Hammarberg T., Gerisch G., Samuelsson B., Radmark O. 5-Lipoxygenase interacts with coactosin-like protein. J Biol Chem 2001, 276:16520-16527.
71. Hung R.J., Yazdani U., Yoon J., Wu H., Yang T., Gupta N., Huang Z., van Berkel W.J., Terman J.R. Mical links semaphorins to F-actin disassembly. Nature 2010, 463:823-827.
72. Terman J.R., Mao T., Pasterkamp R.J., Yu H.H., Kolodkin A.L. MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion. Cell 2002, 109:887-900.
73. Hung R.-J., Terman J.R. Extracellular inhibitors, repellents, and Semaphorin/Plexin/MICAL-mediated actin filament disassembly. Cytoskeleton 2011, 68:415-433.
74. Laing N.G., Dye D.E., Wallgren-Pettersson C., Richard G., Monnier N., Lillis S., Winder T.L., Lochmuller H., Graziano C., Mitrani-Rosenbaum S., et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat 2009, 30:1267-1277.
75. Bender N., Fasold H., Kenmoku A., Middelhoff G., Volk K.E. The selective blocking of the polymerization reaction of striated muscle actin leading to a derivative suitable for crystallization. Modification of Tyr-53 by 5-diazonium-(1H)tetrazole. Eur J Biochem 1976, 64:215-218.
76. Waelkens E., Gettemans J., De Corte V., De Ville Y., Goris J., Vandekerckhove J., Merlevede W. Microfilament dynamics: regulation of actin polymerization by actin-fragmin kinase and phosphatases. Adv Enzyme Regul 1995, 35:199-227.
77. + channels by protein kinase A requires actin filaments. Am J Physiol 1993, 265:C224-C233.
78. Ohta Y., Akiyama T., Nishida E., Sakai H. Protein kinase C and cAMP-dependent protein kinase induce opposite effects on actin polymerizability. FEBS Lett 1987, 222:305-310.
79. Solomon V., Goldberg A.L. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996, 271:26690-26697.
80. Polge C., Heng A.E., Jarzaguet M., Ventadour S., Claustre A., Combaret L., Bechet D., Matondo M., Uttenweiler-Joseph S., Monsarrat B., et al. Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1. FASEB J 2011, 25:3790-3802.
81. Cohen S., Brault J.J., Gygi S.P., Glass D.J., Valenzuela D.M., Gartner C., Latres E., Goldberg A.L. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 2009, 185:1083-1095.
82. Kudryashova E., Kudryashov D., Kramerova I., Spencer M.J. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J Mol Biol 2005, 354:413-424.
83. Field S.J., Pinder J.C., Clough B., Dluzewski A.R., Wilson R.J., Gratzer W.B. Actin in the merozoite of the malaria parasite, Plasmodium falciparum. Cell Motil Cytoskeleton 1993, 25:43-48.
84. Dantan-Gonzalez E., Rosenstein Y., Quinto C., Sanchez F. Actin monoubiquitylation is induced in plants in response to pathogens and symbionts. Mol Plant Microbe Interact 2001, 14:1267-1273.
85. Burgess S., Walker M., Knight P.J., Sparrow J., Schmitz S., Offer G., Bullard B., Leonard K., Holt J., Trinick J. Structural studies of arthrin: monoubiquitinated actin. J Mol Biol 2004, 341:1161-1173.
86. Vertegaal A.C., Ogg S.C., Jaffray E., Rodriguez M.S., Hay R.T., Andersen J.S., Mann M., Lamond A.I. A proteomic study of SUMO-2 target proteins. J Biol Chem 2004, 279:33791-33798.
87. Rosas-Acosta G., Russell W.K., Deyrieux A., Russell D.H., Wilson V.G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics 2005, 4:56-72.
88. Hofmann W.A., Arduini A., Nicol S.M., Camacho C.J., Lessard J.L., Fuller-Pace F.V., de Lanerolle P. SUMOylation of nuclear actin. J Cell Biol 2009, 186:193-200.
89. Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J., Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005, 336:496-506.
90. Cimmino A., Capasso R., Muller F., Sambri I., Masella L., Raimo M., De Bonis M.L., D'Angelo S., Zappia V., Galletti P., et al. Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One 2008, 3:e3258.
91. Zhu J.X., Doyle H.A., Mamula M.J., Aswad D.W. Protein repair in the brain, proteomic analysis of endogenous substrates for protein l-isoaspartyl methyltransferase in mouse brain. J Biol Chem 2006, 281:33802-33813.
92. Stadler J., Gerisch G., Bauer G., Deppert W. In vivo acylation of Dictyostelium actin with palmitic acid. EMBO J 1985, 4:1153-1156.
93. Rioux V., Galat A., Jan G., Vinci F., D'Andrea S., Legrand P. Exogenous myristic acid acylates proteins in cultured rat hepatocytes. J Nutr Biochem 2002, 13:66-74.
94. Bano M.C., Jackson C.S., Magee A.I. Pseudo-enzymatic S-acylation of a myristoylated yes protein tyrosine kinase peptide in vitro may reflect non-enzymatic S-acylation in vivo. Biochem J 1998, 330(Pt 2):723-731.
95. Utsumi T., Sakurai N., Nakano K., Ishisaka R. C-terminal 15 kDa fragment of cytoskeletal actin is posttranslationally N-myristoylated upon caspase-mediated cleavage and targeted to mitochondria. FEBS Lett 2003, 539:37-44.
96. Schick B.P., Jacoby J.A. Sulfation of guinea pig megakaryocyte and platelet proteins. J Cell Physiol 1994, 159:356-364.
97. Kurogi K., Sakakibara Y., Kamemoto Y., Takahashi S., Yasuda S., Liu M.C., Suiko M. Mouse cytosolic sulfotransferase SULT2B1b interacts with cytoskeletal proteins via a proline/serine-rich C-terminus. FEBS J 2010, 277:3804-3811.
98. Mustafa A.K., Gadalla M.M., Sen N., Kim S., Mu W., Gazi S.K., Barrow R.K., Yang G., Wang R., Snyder S.H. H2S signals through protein S-sulfhydration. Sci Signal 2009, 2:ra72.
99. Walsh C.T. Posttranslational Modifications of Proteins. Expanding Nature's Inventory 2006, Roberts and Company Publishers, Englewood, CO.